FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The FDA approves Biogen's supplemental application for TECFIDERA (dimethyl fumarate), indicating an additional regulatory action related to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

SUPPL AP for TECFIDERA (DIMETHYL FUMARATE)